Elanix Biotechnologies SA
Progenitor cells for accelerated tissue healing
Elanix Biotechnologies SA develops and commercializes tissue regeneration products for acute and chronic wound care, and advanced skin care products for dermatological and gynaecological applications. Additionally, Elanix provides services in cell therapy and related technologies.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
08.08.2017
First Clinical Study with Elanix’ Progenitor Cells (startupticker.ch)
08.08.2017
First Clinical Study with Elanix? Progenitor Cells (startupticker.ch)
02.06.2017
Elanix Biotechnologies lance la commercialisation de la crème GYNrepair (startupticker.ch)
02.06.2017
Elanix Biotechnologies lance la commercialisation de la crème GYNrepair (startupticker.ch)
03.05.2017
Elanix ramps up commercialisation and marketing (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Elanix Biotechnologies SA
Progenitor cells for accelerated tissue healing
Website:
www.elanixbiotechnologies.com
Headquarter:
Nyon
Foundation Date:
January 2012
Technology:
- Biotech
Sectors:
- Biotech
- Wound management